Corporate social responsibility, or CSR, has evolved significantly over the past two decades. What was once largely a public relations exercise has become, for many organizations, a genuine framework for considering the broader impact of business decisions on communities, workers, and the environment. Within this framework, companies in industries with a history of asbestos use face a particular set of obligations and opportunities.

Mesothelioma is not a disease of the past. More than 3,000 Americans are diagnosed with this rare and aggressive cancer every year, the vast majority of them as a direct result of occupational asbestos exposure that took place decades earlier. The workers who were exposed, and the families who experience secondary exposure when asbestos fibers were unknowingly carried home, continue to live with the consequences of decisions made by corporations that understood the risks of asbestos far earlier than they publicly acknowledged. Understanding how businesses today can respond with genuine responsibility is an important part of any meaningful CSR conversation.

Acknowledging Historical Responsibility

The first and most difficult step for companies with asbestos in their history is honest acknowledgment. Internal records from asbestos manufacturers and major industrial users reveal that many companies were aware of the health dangers associated with asbestos exposure as early as the 1930s and 1940s. Some actively suppressed this information, funded studies designed to create doubt about the science, and fought against safety regulations for decades while their workers continued to be exposed.

For companies or their successors still in operation, genuine CSR in this context begins with transparency. Maintaining open access to historical records, cooperating with legitimate research into occupational exposure histories, and acknowledging the harm caused by past practices are foundational steps. These actions may carry legal risk, but they also represent the kind of institutional honesty that forms the basis of meaningful trust with workers, communities, and the public.

Supporting Compensation Funds and Legal Access

One of the most concrete ways that companies can support mesothelioma victims is by ensuring that asbestos trust funds remain adequately funded and accessible. When major asbestos manufacturers and users filed for bankruptcy in the face of mounting litigation, courts required them to establish trust funds to compensate current and future victims. More than $30 billion remains available in these funds, but accessing that money requires navigating a complex claims process that can be daunting for seriously ill patients and their families.

Companies that participated in the creation of these funds can take an active CSR role by advocating for transparent and efficient claims processing, supporting the organizations that help victims navigate the system, and resisting efforts to reduce or cap the funds available to claimants. Corporate legal departments that historically fought every claim aggressively can reconsider whether that approach reflects the company’s stated values, particularly when the claimants are elderly workers with terminal diagnoses and limited time.

Investing in Mesothelioma Research

Mesothelioma remains one of the most difficult cancers to treat. Because of its long latency period, which can stretch from 20 to 50 years between initial exposure and diagnosis, most patients are diagnosed at an advanced stage when curative treatment is rarely possible. Research into early detection methods, novel therapies, and immunotherapy approaches holds real promise but is chronically underfunded relative to more common cancers.

Companies with a history of asbestos use can direct a meaningful portion of their CSR budgets toward mesothelioma research. Partnerships with academic medical centers and cancer research institutions, grants to advocacy organizations, and funding for clinical trials are all ways that corporate resources can translate into better outcomes for patients. Some companies have established dedicated foundations for this purpose, creating a lasting institutional commitment that extends beyond individual business cycles.

Supporting Advocacy and Awareness Organizations

Mesothelioma advocacy organizations perform essential work connecting patients with resources, providing support to families, and pushing for policy changes that protect future workers from asbestos exposure. Many of these organizations operate on limited budgets and depend on donations and partnerships to sustain their work.

Corporate sponsorships, employee giving programs, and pro bono professional services are all channels through which businesses can provide meaningful support. Legal firms, medical groups, financial planning services, and communications professionals all have skills that are directly valuable to mesothelioma patients and their families. Organizing structured volunteer programs that direct these skills toward patient advocacy organizations can generate real impact alongside the reputational benefits that typically motivate CSR investment.

Strengthening Workplace Safety for Current Workers

For companies still operating in industries where asbestos exposure remains a risk, including construction, shipbuilding, firefighting, and certain manufacturing sectors, one of the most important CSR commitments is ensuring that current workers are not the mesothelioma patients of the future. This means exceeding regulatory minimums on asbestos safety, investing in exposure monitoring, providing high-quality protective equipment, and conducting regular medical surveillance for at-risk workers.

It also means being honest with workers about the risks they face. Workers who understand the connection between asbestos exposure and mesothelioma are better positioned to protect themselves and to make informed decisions about their own health care. Informed workers can also act as advocates for safety within their own workplaces, reinforcing a culture where hazard awareness is shared responsibility rather than a top-down mandate.

The Intersection of CSR and Legal Obligation

It is worth noting that for companies facing mesothelioma litigation, the boundary between CSR and legal obligation is not always sharp. Settling legitimate claims fairly and promptly, rather than engaging in years of delay tactics that harm seriously ill patients, is both an ethical choice and a reflection of corporate values. Companies that genuinely embrace responsibility for the harm caused by asbestos tend to build more durable reputations and healthier relationships with the communities in which they operate than those that fight accountability at every turn.

Supporting mesothelioma victims is not just the right thing to do. For companies with asbestos in their history, it is an essential expression of the values they claim to hold.

Deep Dive Reading